Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-22T16:27:02.515Z Has data issue: false hasContentIssue false

A Trial of Fluphenazine Enanthate in Chronic Schizophrenia

Published online by Cambridge University Press:  29 January 2018

John Millar
Affiliation:
Carlton Hayes Hospital, Narborough, Leicester
G. R. Daniel
Affiliation:
E. R. Squibb & Sons Limited, Regal House, Twickenham, Middlesex

Extract

It has been shown by Parkes (1) and other workers that about 45 per cent. of out-patient schizophrenics are unreliable at taking their phenothiazine medication. It is in this group that many relapse and require readmission to hospital. Kline (2) quotes that 20 per cent. of in-patients are also unreliable in this regard. With the advent of a long-action phenothiazine injection fluphenazine enanthate, control of these difficult patients may well prove more effective.

Type
Abstract
Copyright
Copyright © Royal College of Psychiatrists, 1967 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Parkes, C. M., Brown, G. W., and Monck, E. M. (1962). Brit. med. J., i, 972.CrossRefGoogle Scholar
2. Kline, N. S., and Simpson, G. M., (1964). Amer. J. Psychiat., 120, 1012.Google Scholar
3. Millar, J. (1963). Brit. J. Psychiat., 109, 428.CrossRefGoogle Scholar
4. National Institute of Health Multi-Centre Trial (1964). Arch. gen. Psychiat., 10, 246.CrossRefGoogle Scholar
5. Kinross-Wright, J., and Charalampous, K. D. (1965). Int. J. Neuropsychiat., 1, 66.Google Scholar
6. Hamilton, M., Smith, A. L. G., Lapidus, H. E., and Cadogan, E. P. (1960). J. ment. Sci., 106, 40.Google Scholar
7. Baker, A. A., and Thorpe, J. G. (1956). Ibid., 102, 838.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.